Short Interest in TherapeuticsMD, Inc. (NASDAQ:TXMD) Decreases By 27.6%

TherapeuticsMD, Inc. (NASDAQ:TXMD) was the target of a large decrease in short interest in January. As of January 31st, there was short interest totalling 173,800 shares, a decrease of 27.6% from the January 15th total of 240,200 shares. Based on an average daily volume of 289,900 shares, the short-interest ratio is presently 0.6 days. Approximately 1.5% of the company’s stock are short sold.

TherapeuticsMD Stock Performance

TXMD opened at $1.03 on Friday. TherapeuticsMD has a twelve month low of $0.70 and a twelve month high of $2.75. The company’s 50-day moving average price is $1.10 and its two-hundred day moving average price is $1.43.

Analyst Ratings Changes

Separately, StockNews.com began coverage on shares of TherapeuticsMD in a research report on Tuesday, January 14th. They issued a “hold” rating for the company.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.